Introduction: The Structural Problem the Case Raises
The decision revisits a long-standing structural feature of Indian patent law: the disjunction between the commencement of the patent term and the accrual of enforceable rights. Section 53 of the Patents Act, 1970 fixes the 20-year patent term from the date of filing. Section 11A(7) bars infringement proceedings until grant. Where the Patent Office takes years to grant a patent, the result is that the patent term runs during a period when the patentee cannot sue for infringement.
The appellants in this case experienced this gap directly. They filed a patent application in May 2005. It was granted in December 2012, seven years later. By the time grant arrived, roughly one-third of the 20-year statutory term had already elapsed with no infringement remedy available. They approached the Calcutta High Court seeking constitutional relief.
The Indian patent system does not guarantee a full 20-year period of enforceable exclusivity, but rather a 20-year statutory term subject to procedural contingencies. Delay in grant, absent demonstrable arbitrariness or mala fides, does not justify judicial interference with the patent term.
The Three-Stage Framework: How Rights Accrue Under the Act
The Court’s reasoning rests on a clear mapping of the three stages through which a patent application passes and the rights that attach at each stage. Understanding this framework is essential for any patent applicant managing a pending application.
| Stage | Rights Available | Can Sue for Infringement? |
| Filing to Publication | Right to claim priority over subsequent applications. No other rights accrue. Third parties are not on notice of the application’s contents. | No |
| Publication to Grant | Interim rights under Section 11A(7): equivalent to rights of a granted patentee, including the right to claim damages from the date of publication. No right to file an infringement action. | No (damages only, after grant) |
| Grant onwards | Full patent rights under Section 48, including the exclusive right to use, make, sell, and import. Right to institute infringement proceedings. Damages claimable from publication date. | Yes |
The Court held that Sections 53 and 11A(7) operate at different stages of this framework and serve distinct but complementary purposes. Section 53 fixes the outer boundary of patent life. Section 11A(7) governs what rights exist within that term before grant. There is no internal contradiction: the provisions simply address different moments in the patent’s lifecycle.
Factual Background and Procedural History
The patent application in question was filed on 2 May 2005 and the patent was granted on 28 December 2012. In accordance with Section 53, the term of the patent was calculated as 20 years from the filing date, expiring in 2025.
Aggrieved by the seven-year delay in grant, the appellants argued that they were effectively deprived of meaningful patent protection during the pendency period, as Section 11A(7) bars infringement proceedings prior to grant. Multiple writ proceedings preceded the present appeal, culminating in a direct challenge to the constitutional validity of Section 53 of the Act.
Issues for Determination
The principal issues before the Court were:
- Whether Section 53 of the Patents Act, 1970, which fixes the patent term from the date of filing, is unconstitutional when read alongside Section 11A(7).
- Whether the inability to enforce patent rights prior to grant warrants judicially mandated extension of the patent term.
- Whether the alleged delay in grant renders the statutory scheme arbitrary or violative of constitutional guarantees.
Submission of the Parties
Appellants’ case
The appellants contended that Section 53, read with Section 11A(7), creates an internal inconsistency by allowing the patent term to run during a period when enforcement is statutorily barred. This results in a disproportionate erosion of proprietary rights and violates Article 14 of the Constitution on grounds of arbitrariness and inequality. They sought either a 15-year extension of the patent term, a reading down of Section 53, or a declaration that the section was ultra vires. Reliance was placed on the US Patent Term Adjustment framework to argue that delay-based compensation is both feasible and equitable.
On renewal fees, they argued that requiring payment of maintenance fees during a period of non-enforceability amounted to an unfair burden violating Article 22.
Respondents’ case
The respondents raised res judicata as a threshold objection, pointing to the multiple prior dismissals of the same challenge. On the merits, they contended that Sections 53 and 11A(7) operate in entirely different statutory domains and are not contradictory. Patent rights are purely statutory, accrue only upon grant, and policy choices relating to patent term and delay fall squarely within the legislative sphere and cannot be corrected by constitutional adjudication.
Decision and Reasoning of the Division Bench
The Division Bench upheld the constitutionality of Section 53 and dismissed the appeal on four grounds.
1. Term and enforcement are governed by distinct statutory logics
Section 53 determines the lifespan of a patent. Section 11A(7) governs interim privileges following publication. The two provisions are complementary, not contradictory. Section 53 ensures compliance with TRIPS Article 33, which mandates a minimum term of 20 years from the filing date. Section 11A(7) provides a mechanism for interim protection in the period between publication and grant. Treating them as inconsistent would misread the architecture of the Act.
2. Patent rights crystallise only upon grant
Prior to grant, the applicant enjoys limited statutory privileges. The absence of a right to sue for infringement before grant is a conscious legislative choice, not a constitutional infirmity. The gradation of rights across the three stages of the patent process was held not to be unreasonably discriminatory, satisfying the test under Article 14.
3. Patent term adjustment is a matter for the legislature, not the court
The US Patent Term Adjustment analogy was expressly rejected. The introduction of patent term extensions or adjustments is a matter of legislative policy. The Court cited findings from an expert committee that had previously examined the feasibility of expedited examination and Patent Term Adjustment in the Indian context and concluded that PTA, as implemented in the United States, was unsuitable for India given concerns around prolonged monopolies and technological obsolescence. These policy conclusions were for Parliament to act upon, not courts.
4. The patent is not commercially sterile during pendency
Nothing in Indian law prevents patentees from pursuing commercialisation, licensing negotiations, or regulatory approvals during the pendency of an application. The absence of enforcement remedies does not render the patent commercially inert. Enforcement is only one axis of utility. The judgment therefore aligns legal doctrine with commercial reality: strategic value can and does accrue before grant.
Analysis
The judgment is doctrinally conservative but structurally important. It resists the increasingly common attempt to frame patent delay as a constitutional injury rather than a policy issue. By refusing to conflate term, rights, and remedies, the Court preserves the internal coherence of the Patents Act.
Notably, the Court’s reasoning underscores that patents in India are statutory monopolies, not natural or property rights in the classical sense. Consequently, claims of deprivation must be tested strictly against the text and intent of the statute, not against comparative dissatisfaction with foreign regimes.
The decision also implicitly endorses a transactional view of patent value. Enforcement is only one axis of utility; commercial leverage, licensing negotiations, and market positioning can and do occur well before grant. The judgment therefore aligns legal doctrine with commercial reality.
Conclusion
The Calcutta High Court’s decision in Gunjan Sinha conclusively affirms that the Indian patent system does not guarantee a full 20-year period of enforceable exclusivity, but rather a 20-year statutory term subject to procedural contingencies. Delay in grant, absent demonstrable arbitrariness or mala fides, does not justify judicial interference with the patent term.
Any move towards patent term compensation or adjustment must emerge from legislative reform, not constitutional adjudication. Until then, the law remains clear: enforcement begins at grant, the clock starts at filing, and strategic value must be extracted in the space between.
Governing Law
Patents Act, 1970: Section 11A(7), Section 45(3), Section 48, Section 53 | Patent Rules, 2003: Rule 80 | Constitution of India: Article 14, Article 226 | TRIPS Agreement: Article 33
